Get it on Google Play

Veltassa Black Box Warning Removed

November 28, 2016 5:57 AM EST

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Galenica Group today announced that Relypsa, Inc., a Vifor Pharma Company, has received approval from the US Food and Drug Administration (FDA) for a supplemental New Drug Application (sNDA) with important updates to the US label of Veltassa (patiromer) for oral suspension. The US label for Veltassa no longer includes a Boxed Warning regarding the separation of Veltassa and other oral medications.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Add Your Comment